Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 475 results for "panacea biotec"

Cough Therapeutics Pipeline Review 2015 Featuring 34 Companies

Research and Markets (http://www.researchandmarkets.com/research/qpt4xp/cough_pipeline) has announced the addition of the "Cough - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic ... Individual.com, 2 days ago
Global Travel Vaccines Market 2015-2019 Wall Street Business Network, 2 days ago
[x]  

PTO Litigation Center Report March 16, 2015

Listed below are all new filings before PTAB of requests forinter partesreview (IPR) and covered business methods review (CBM). Also listed are any newly-posted requests forex partereexamination at the USPTO. This listing is current as of noon on ...
 National Law Review1 week ago

Panacea Biotec gets PAHO order for supply of Easy Five-TT vaccines worth $13.49 mn

Panacea Biotec, among the largest producer of vaccines and a research based pharmaceutical and biotechnology company has been elected for supply of Pentavalent Vaccine DTP-HepB-Hib by Pan American Health Organization (PAHO). The company has been ...
 Financial Express1 month ago Panacea Biotec bags Rs 83 cr order to supply EasyFive-TT vaccine  Hindu Business Line1 month ago Panacea Biotec gets $13.5 mn order from PAHO  Business Standard1 month ago Panacea Biotec gains on wining Rs 83.52 vaccine order  Business Standard1 month ago
[x]  

Panacea Biotec reports standalone net loss of Rs 3.48 crore in the December 2014 quarter

Sales rise 30.58% to Rs 138.15 crore Net loss of Panacea Biotec reported to Rs 3.48 crore in the quarter ended December 2014 as against net profit of Rs 82.79 crore during the previous quarter ended December 2013. Sales rose 30.58% to Rs 138.15 crore in the ...
 Business Standard1 month ago Panacea Biotec eyes Rs. 90 crore EBITDA in this year: Rajesh Jain  India Infoline1 month ago Eyeing EBITDA over Rs 90 cr next year: Panacea Biotech  Moneycontrol.com1 month ago Sahara Housing Finance Q3 net at Rs 65 lakh  Business Standard India1 month ago

Panacea Biotec gains on allotting preference shares to promotes

Capital Market January 6, 2015 Last Updated at 14:29 IST Panacea Biotec rose 0.26% to Rs 149.75 at 14:35 IST on BSE after the company said that it had allotted 1.63 crore, non-convertible cumulative redeemable preference shares on private placement ...
 Business Standard India2 months ago Panacea Biotec raises Rs 16.3 crore  Business Standard India2 months ago Panacea Biotec allots NCCR Preference Shares  Capital Market2 months ago Panacea Biotec allots 1.63cr redeemable preference shares  Moneycontrol.com2 months ago
[x]  

Opportunity in the Indian Anti-Diabetic Pharmaceuticals Market - 2015; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

FEATURED COMPANIES Biocon Limited Cipla Ltd. Merck Ltd. Panacea Biotec Ltd. Ranbaxy Laboratories Ltd. Strides Arcolab Ltd. MORE This report provides an insight into the ...
 Research and Markets2 weeks ago

Immense scope for research in Biotechnology

In Biotechnology, new areas of study and research emerge continuously. In the previous article, we had highlighted the salient aspects of Biotechnology in very broad terms. Research areas in Biotechnology include genomics, bioinformatics, plant ...
 The Hindu1 month ago

India Pharma Outlook 2015: Accelerating growth to the next level: Moving up the value chain beyond Generics

Domestic sales improved in 2014, recovering from the slump in the 2013 caused by the market's reaction to the new drug pricing policy. In 2015, growth is expected to continue to be healthy, as the momentum continues and improving economic growth ...
 Global Information Inc4 weeks ago

Waking up at last to the swine flu threat

Associate editor E Kumar Sharma On February 17, a circular signed by the Drug Controller General of India was issued to seven companies that make the vaccine for the 'H1N1 influenza', medical jargon for what we all know as Swine Flu . The companies ...
 Business Today India1 month ago

'Vaccines-makers must meet demand'

AHMEDABAD: In the wake of alarming rise in swine flu cases, Central Drugs Standard Control Organisation (CDSCO), Union ministry of health and welfare, has asked vaccine manufacturers to ensure adequate supply of H1N1 vaccine and Trivalent Seasonal ...
 Times of India1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - panacea biotec
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less